Publications by authors named "A J Ekstrand"
Cytomegalovirus (CMV) infections remain a common problem after solid-organ transplantation. We characterized the burden of CMV infections, and adverse events of CMV prophylaxis after simultaneous pancreas-kidney transplantation (SPK). We included all SPK patients ( = 236) since 2010 in our country.
View Article and Find Full Text PDFBackground: Kidney living donation carries risks, yet standardized information provision regarding nephrectomy risks and psychological impacts for candidates remains lacking.
Objective: This study assesses the benefit of interactive health technology in improving the informed consent process for kidney living donation.
Methods: The Kidney Hub institutional open portal offers comprehensive information on kidney disease and donation.
The total burden of infections after transplantation has not been compared in detail between recipients of simultaneous pancreas-kidney transplantation (SPK) and kidney transplantation alone (KTA). We compared infection-related hospitalizations and bacteremias after transplantation during 1- and 5-year follow-up among 162 patients undergoing SPK. The control group consisted of 153 type 1 diabetics undergoing KTA with the inclusion criteria of donor and recipient age < 60, and BMI < 30.
View Article and Find Full Text PDFArticle Synopsis
- Peritoneal dialysis is recommended as a first-line treatment for kidney replacement, especially for vulnerable patients, but it often requires assistance that can involve family or specialized caregivers in institutional settings.
- A group of nephrologists from 13 European countries shared their insights on implementing assisted peritoneal dialysis, discussing the challenges and solutions that can help establish effective programs.
- The findings indicate that assisted peritoneal dialysis isn't a fixed approach and can be tailored to individual needs, allowing for flexible care options that can ultimately lead to greater patient autonomy.
Introduction: Simultaneous pancreas-kidney transplantation (SPK) is an option for patients with type 1 diabetes (T1D) and kidney failure but can be associated with a high complication rate. Here we describe our 10-year experience since the launch of the SPK program.
Methods: This retrospective study included consecutive patients with T1D receiving SPK from March 14, 2010 to March 14, 2020 at Helsinki University Hospital.